Award recordCONTRACT

UCB, INC

PIID 36C26026F0046· VHA· 260-NETWORK CONTRACT OFFICE 20 (36C260)· 6505 · DRUGS AND BIOLOGICALS· FY2026· $371,175 net obligations· UEI F3N9Q9TY2BC9· GA

Description

ZILBRYSQ 32.4MG/0.81ML INJ,SOLN SY. 2026 PRICE INCREASE

Base award description: ZILBRYSQ 32.4MG/0.81ML INJ,SOLN SY.

First action · last action
2025-10-07 · 2026-03-02
Transactions
2
First transaction's obligation
$367,226
Base + all options value (sum of deltas)
$371,175
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79725D0227
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$371,175$0Base award · 2025-10-07 · this action $367,226 · running total $367,226Modification P00001 · 2026-03-02 · this action $3,949 · running total $371,175
  • Base2025-10-07+$367,226= $367,226
  • Mod P000012026-03-02+$3,949= $371,175
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2025-10-07+$367,226$367,226ZILBRYSQ 32.4MG/0.81ML INJ,SOLN SY.
Mod P00001· FUNDING ONLY ACTION2026-03-02+$3,949$371,175ZILBRYSQ 32.4MG/0.81ML INJ,SOLN SY. 2026 PRICE INCREASE

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI F3N9Q9TY2BC9)

AwardOffice · PSC / listingNet obligationsFY
36C24526F0346245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$31,041FY2026
36C24526N0727245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$31,041FY2026
36C24526N0666245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$31,041FY2026
36C24526N0574245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$31,041FY2026
36C24526N0526245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$31,041FY2026
36C24526N0378245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$31,041FY2026

Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26026F0379COSETTE PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$3,466FY2026
36C26026P0671MCKESSON PLASMA AND BIOLOGICS LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$18,262FY2026
36C26026F0349AGIOS PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$73,080FY2026
36C26026F0306BRACCO DIAGNOSTICS INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$337,422FY2026
36C26026F0298PROGENICS PHARMACEUTICALS INC260-NETWORK CONTRACT OFFICE 20 (36C260)$469,134FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26026F0046_3600_36F79725D0227_3600 · retrieved 2026-09-26.